Jennifer Jarrett

Jennifer Jarrett is the current Director at Syndax. Prior to this, they held the position of Head of Corporate Development and Capital Markets at Uber from January 2019 to October 2020. Jennifer was also a Board Member at Consonance HFW Acquisition from December 2020 to August 2021, before it was acquired by Astellas. Prior to their time at Uber, Jennifer was a Board Member at Arena Pharmaceuticals, Inc. from July 2017 to March 2022, where they were a member of the Audit Committee and Nom & Gov Committee. Jennifer was also a Board Member at Audentes Therapeutics from July 2017 to January 2020, before it was acquired by Astellas. Jennifer has also served as the Chief Operating Officer at Arcus Biosciences and as the CFO at Medivation from April 2016 to October 2016. Before their time in the biotech industry, Jennifer worked as a Managing Director in Health Care Investment Banking at Citigroup from July 2010 to April 2016.

Jennifer Jarrett has a MBA from Stanford University Graduate School of Business and a BA in Economics from Dartmouth College.